144 related articles for article (PubMed ID: 19477024)
1. Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model.
Belmar NA; Lombardo JR; Chao DT; Li O; Ma X; Pong-Afar M; Law DA; Starling GC
J Neuroimmunol; 2009 Jul; 212(1-2):65-73. PubMed ID: 19477024
[TBL] [Abstract][Full Text] [Related]
2. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
3. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
Donckier V; Flament V; Gérard C; Abramowicz D; Vandenabeele P; Wissing M; Delvaux A; Fiers W; Leo O; Velu T
Transplantation; 1994 May; 57(10):1436-9. PubMed ID: 8197603
[TBL] [Abstract][Full Text] [Related]
5. Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis.
Jensen MA; Arnason BG; Toscas A; Noronha A
J Autoimmun; 1996 Oct; 9(5):587-97. PubMed ID: 8933274
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
Lavasani S; Dzhambazov B; Andersson M
Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
[TBL] [Abstract][Full Text] [Related]
7. The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibody.
Routledge EG; Falconer ME; Pope H; Lloyd IS; Waldmann H
Transplantation; 1995 Oct; 60(8):847-53. PubMed ID: 7482746
[TBL] [Abstract][Full Text] [Related]
8. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
Cole MS; Anasetti C; Tso JY
J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Hofstetter HH; Ibrahim SM; Koczan D; Kruse N; Weishaupt A; Toyka KV; Gold R
Cell Immunol; 2005 Oct; 237(2):123-30. PubMed ID: 16386239
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.
Allen SJ; Baker D; O'Neill JK; Davison AN; Turk JL
Cell Immunol; 1993 Feb; 146(2):335-50. PubMed ID: 8174174
[TBL] [Abstract][Full Text] [Related]
11. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
13. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.
Ishikawa H; Ochi H; Chen ML; Frenkel D; Maron R; Weiner HL
Diabetes; 2007 Aug; 56(8):2103-9. PubMed ID: 17456848
[TBL] [Abstract][Full Text] [Related]
15. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
16. An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation.
Byrne FR; Winters A; Brankow D; Hu S; Juan T; Steavenson S; Doellgast G; Kuchimanchi K; Brown H; Anderson S; Smelt S; Sullivan T; Alcorn D; Tocker J; Dean C; Macmaster J; Kirchner J; Buys J; Manoukian R; Jiao E; Zou X; Campanella GS; Siu G
Autoimmunity; 2009 Mar; 42(3):171-82. PubMed ID: 19301198
[TBL] [Abstract][Full Text] [Related]
17. Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis.
Uyttenhove C; Sommereyns C; Théate I; Michiels T; Van Snick J
Ann N Y Acad Sci; 2007 Sep; 1110():330-6. PubMed ID: 17911448
[TBL] [Abstract][Full Text] [Related]
18. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.
Ochi H; Abraham M; Ishikawa H; Frenkel D; Yang K; Basso AS; Wu H; Chen ML; Gandhi R; Miller A; Maron R; Weiner HL
Nat Med; 2006 Jun; 12(6):627-35. PubMed ID: 16715091
[TBL] [Abstract][Full Text] [Related]
19. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R
J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871
[TBL] [Abstract][Full Text] [Related]
20. In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis.
Chen W; Li H; Jia Y; Lv M; Li M; Feng P; Hu H; Zhang L
J Autoimmun; 2007 Feb; 28(1):30-40. PubMed ID: 17267177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
